We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.71B
1-Year Est. Return 65.19%
This Fund
S&P 500
This Quarter Est. Return
+5.72%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.14B
AUM Growth
-$171M
Cap. Flow
-$231M
Cap. Flow %
-7.38%
Top 10 Hldgs %
16.05%
Holding
444
New
72
Increased
89
Reduced
94
Closed
73

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$29.5M
2
MIDD icon
Middleby
MIDD
+$25.9M
3
PH icon
Parker-Hannifin
PH
+$25.1M
4
VEEV icon
Veeva Systems
VEEV
+$23M
5
DKS icon
Dick's Sporting Goods
DKS
+$22.8M

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$43.4M
2
PXD
Pioneer Natural Resource Co.
PXD
+$35.2M
3
TDG icon
TransDigm Group
TDG
+$29.9M
4
V icon
Visa
V
+$28.6M
5
BMY icon
Bristol-Myers Squibb
BMY
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 19.27%
2 Energy 16.11%
3 Healthcare 14.04%
4 Industrials 13.84%
5 Consumer Discretionary 11.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAT icon
351
Caterpillar
CAT
$360B
$139K ﹤0.01%
1,500
– –
ORCL icon
352
Oracle
ORCL
$433B
$115K ﹤0.01%
3,000
– –
ABBV icon
353
AbbVie
ABBV
$464B
$113K ﹤0.01%
1,800
– –
AVGO icon
354
Broadcom
AVGO
$1.62T
$110K ﹤0.01%
6,200
– –
BAP icon
355
Credicorp
BAP
$30.3B
$106K ﹤0.01%
670
– –
TTM
356
DELISTED
Tata Motors Limited
TTM
$105K ﹤0.01%
3,060
– –
NKE icon
357
Nike
NKE
$53.1B
$102K ﹤0.01%
2,000
– –
RACE icon
358
Ferrari
RACE
$72.4B
$100K ﹤0.01%
+1,725
New +$94.1K
MCD icon
359
McDonald's
MCD
$176B
$97K ﹤0.01%
800
– –
LBTYA icon
360
Liberty Global Class A
LBTYA
$3.55B
$93K ﹤0.01%
3,055
– –
AGN
361
DELISTED
Allergan plc
AGN
$93K ﹤0.01%
441
– –
CIB icon
362
Grupo Cibest SA
CIB
$23.2B
$91K ﹤0.01%
2,470
– –
HDB icon
363
HDFC Bank
HDB
$115B
$91K ﹤0.01%
6,000
– –
ABT icon
364
Abbott
ABT
$177B
$69K ﹤0.01%
1,800
– –
CDK
365
DELISTED
CDK Global, Inc.
CDK
$60K ﹤0.01%
1,000
– –
CMI icon
366
Cummins
CMI
$72.6B
$41K ﹤0.01%
300
– –
SYK icon
367
Stryker
SYK
$109B
$41K ﹤0.01%
340
– –
WBA
368
DELISTED
Walgreens Boots Alliance
WBA
$40K ﹤0.01%
480
– –
TIVO
369
DELISTED
Tivo Inc
TIVO
$15K ﹤0.01%
739
– –
CNX icon
370
CNX Resources
CNX
$4.99B
$10K ﹤0.01%
636
– –
CRC
371
DELISTED
California Resources Corporation
CRC
$5K ﹤0.01%
234
– –
ALLE icon
372
Allegion
ALLE
$13B
– –
-43,712
Closed -$3.01M
AMED
373
DELISTED
Amedisys
AMED
– –
-114,510
Closed -$5.43M
ANIP icon
374
ANI Pharmaceuticals
ANIP
$1.69B
– –
-100,615
Closed -$6.68M
ARMK icon
375
Aramark
ARMK
$15.2B
– –
-184,187
Closed -$5.06M
13 14
15
16 17

Similar funds

MSC
MUFG Securities (Canada) New York $3.71B AUM 38.19% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
HCM
Himalaya Capital Management Seattle, Washington $3.7B AUM 39.18% 1-Year Est. Return
OH
Osiris Holdings Monaco $3.72B AUM
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.7B AUM 32.64% 1-Year Est. Return
MCM
MKP Capital Management New York $3.7B AUM 23.18% 1-Year Est. Return

Castleark Management's Q4 2016 Portfolio in Review

As of Q4 2016, Castleark Management held 444 positions worth $3.14B, down 5.2% from $3.31B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Castleark Management withdrew a net $231M in Q4 2016, closing 73 positions and reducing 94 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Castleark Management opened a new position in Morgan Stanley worth $32.9M.

  • Castleark Management's largest Q4 2016 buy was Morgan Stanley: 779,714 shares worth $32.9M.
  • Castleark Management added most to Middleby in Q4 2016, an estimated $25.9M increase.
  • Castleark Management's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $43.4M.
  • Castleark Management fully exited Bristol-Myers Squibb in Q4 2016, selling an estimated $22.8M.
  • Castleark Management's ten largest holdings make up 16% of its $3.14B portfolio in Q4 2016.
  • Castleark Management opened 72 new positions and closed 73 in Q4 2016.
  • Castleark Management's portfolio value fell 5.2% quarter-over-quarter to $3.14B.

Based on Castleark Management's 13F filing for Q4 2016, filed 15 Feb 2017.